John Young, PhD

John Young is the Chief Strategy Officer, Quantitative Biosciences Institute, University of California, San Francisco and is the Founder of JY Scientific Consulting LLC. John was previously the Therapeutic Area Head of Infectious Diseases and Global Head of Pandemic Preparedness, at Roche Pharma Research and Early Development (pRED) in Basel, Switzerland. He served as a Board Member on the AMR Action Fund and on the Intrepid Alliance for Pandemic Prevention, Preparedness and Response. He was also a member of the Leadership Team of the FNIH/NIH-led ACTIV public-private partnership during the COVID-19 pandemic. Prior to Roche, John was a Professor at the Salk Institute for Biological Studies in La Jolla, California. He is a Fellow of the American Academy of Microbiology. He is a recipient of the American Society for Microbiology’s Eli Lilly and Company-ELANCO Research Award, a co-recipient of the NIH Office of the Director’s Award, and a co-recipient of the Charles A. Sanders M.D. Partnership Award from the Foundation for the NIH.